Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 554

1.

The importance of rapid diagnosis for multidrug-resistant Candida: an interview with Maurizio Sanguinetti.

Sanguinetti M.

Future Microbiol. 2019 Aug;14:1011-1012. doi: 10.2217/fmb-2019-0198.

2.

Graphene Oxide Coatings as Tools to Prevent Microbial Biofilm Formation on Medical Device.

Cacaci M, Martini C, Cinzia G, Torelli R, Bugli F, Sanguinetti M.

Adv Exp Med Biol. 2019 Aug 30. doi: 10.1007/5584_2019_434. [Epub ahead of print]

PMID:
31468360
3.

Prenatal valacyclovir treatment of fetal citomegalovirus infection: A case series.

De Santis M, De Luca C, Apicella M, D'Oria L, Lanzone A, Sanguinetti M, Valentini P, Scambia G, Masini L, Santangelo R.

J Infect. 2019 Aug 26. pii: S0163-4453(19)30255-5. doi: 10.1016/j.jinf.2019.08.015. [Epub ahead of print] No abstract available.

PMID:
31465779
4.

Antibiofilm Activity of Three Different Irrigation Techniques: An in Vitro Study.

Eneide C, Castagnola R, Martini C, Grande NM, Bugli F, Patini R, Cordaro M, Sanguinetti M, Olivi G, Isola G, Marigo L.

Antibiotics (Basel). 2019 Aug 9;8(3). pii: E112. doi: 10.3390/antibiotics8030112.

5.

Conjugation of different immunogenic enterococcal vaccine target antigens leads to extended strain coverage.

Romero-Saavedra F, Laverde D, Kalfopoulou E, Martini C, Torelli R, Martinez-Matamoros D, Sanguinetti M, Huebner J.

J Infect Dis. 2019 Jul 9. pii: jiz357. doi: 10.1093/infdis/jiz357. [Epub ahead of print]

PMID:
31289829
6.

A New Strategy for Glioblastoma Treatment: In Vitro and In Vivo Preclinical Characterization of Si306, a Pyrazolo[3,4-d]Pyrimidine Dual Src/P-Glycoprotein Inhibitor.

Fallacara AL, Zamperini C, Podolski-Renić A, Dinić J, Stanković T, Stepanović M, Mancini A, Rango E, Iovenitti G, Molinari A, Bugli F, Sanguinetti M, Torelli R, Martini M, Maccari L, Valoti M, Dreassi E, Botta M, Pešić M, Schenone S.

Cancers (Basel). 2019 Jun 19;11(6). pii: E848. doi: 10.3390/cancers11060848.

7.

Off-site versus on-site clinical microbiology laboratory: a 2-year comparison study of blood culture result reporting.

Posteraro P, Gasparoli C, Errico FM, Massaria G, Sanguinetti M, Posteraro B.

Clin Microbiol Infect. 2019 Jun 22. pii: S1198-743X(19)30366-0. doi: 10.1016/j.cmi.2019.06.021. [Epub ahead of print] No abstract available.

PMID:
31238120
8.

Diagnosis and treatment of invasive fungal infections: looking ahead.

Sanguinetti M, Posteraro B, Beigelman-Aubry C, Lamoth F, Dunet V, Slavin M, Richardson MD.

J Antimicrob Chemother. 2019 Mar 1;74(Supplement_2):ii27-ii37. doi: 10.1093/jac/dkz041.

PMID:
31222314
9.

Collaborative national multicenter for the identification of conversion factors from copies/mL to international units/mL for the normalization of HCMV DNA load.

Sidoti F, Piralla A, Costa C, Scarasciulli ML, Calvario A, Conaldi PG, Paba P, Perno CF, Gaeta A, Antonelli G, Sodano G, Santangelo R, Sanguinetti M, Vatteroni ML, Barzon L, Palù G, Abbate I, Capobianchi MR, Piccirilli G, Lazzarotto T, Baldanti F, Cavallo R.

Diagn Microbiol Infect Dis. 2019 Oct;95(2):152-158. doi: 10.1016/j.diagmicrobio.2019.05.012. Epub 2019 May 25.

PMID:
31204110
10.

'Being a parent at ECCMID 2019' - ESCMID's reply.

Rodríguez-Baño J, Sanguinetti M; ESCMID Executive Committee.

Clin Microbiol Infect. 2019 Sep;25(9):1161. doi: 10.1016/j.cmi.2019.05.018. Epub 2019 Jun 13. No abstract available.

PMID:
31202578
11.

Direct use of eazyplex® SuperBug CRE assay from positive blood cultures in conjunction with inpatient infectious disease consulting for timely appropriate antimicrobial therapy in Escherichia coli and Klebsiella pneumoniae bloodstream infections.

Fiori B, D'Inzeo T, Posteraro B, Menchinelli G, Liotti FM, De Angelis G, De Maio F, Fantoni M, Murri R, Scoppettuolo G, Ventura G, Tumbarello M, Pennestrì F, Taccari F, Sanguinetti M, Spanu T.

Infect Drug Resist. 2019 May 3;12:1055-1062. doi: 10.2147/IDR.S206323. eCollection 2019.

12.

Efficient Inactivation of Clinically Relevant Antimicrobial Drug Concentrations by BacT/Alert or Bactec Resin-Containing Media in Simulated Adult Blood Cultures.

Menchinelli G, Liotti FM, Giordano L, De Angelis G, Sanguinetti M, Spanu T, Posteraro B.

Antimicrob Agents Chemother. 2019 Jun 24;63(7). pii: e00420-19. doi: 10.1128/AAC.00420-19. Print 2019 Jul.

PMID:
31085511
13.

Simplified Testing Method for Direct Detection of Carbapenemase-Producing Organisms from Positive Blood Cultures Using the NG-Test Carba 5 Assay.

Giordano L, Fiori B, D'Inzeo T, Parisi G, Liotti FM, Menchinelli G, De Angelis G, De Maio F, Luzzaro F, Sanguinetti M, Posteraro B, Spanu T.

Antimicrob Agents Chemother. 2019 Jun 24;63(7). pii: e00550-19. doi: 10.1128/AAC.00550-19. Print 2019 Jul.

PMID:
31061162
14.

In Vitro Activity of Fenticonazole against Candida and Bacterial Vaginitis Isolates Determined by Mono- or Dual-Species Testing Assays.

Sanguinetti M, Cantón E, Torelli R, Tumietto F, Espinel-Ingroff A, Posteraro B.

Antimicrob Agents Chemother. 2019 Jun 24;63(7). pii: e02693-18. doi: 10.1128/AAC.02693-18. Print 2019 Jul.

PMID:
31061161
15.

The role of procalcitonin outside of the Intensive Care Unit (ICU): a multidisciplinary approach.

Fantoni M, Taddei E, Cauda R, Antonelli Incalzi R, Capone A, Cortese F, Sanguinetti M, Spandonaro F, Urbani A, Murri R.

Eur Rev Med Pharmacol Sci. 2019 Apr;23(7):2978-2985. doi: 10.26355/eurrev_201904_17579.

16.

Gastrointestinal basidiobolomycosis in a patient suffering from duodenal ulcer with perforation: First case report from Italy.

Parisio EM, Camarlinghi G, Nardone M, De Carolis E, Mattei R, Sanguinetti M.

New Microbiol. 2019 Apr;42(2):125-128. Epub 2019 Apr 17.

17.

Antifungal properties of silver coating on tumour endoprostheses: an in vitro study.

D'Adamio S, Ziranu A, Cazzato G, Sanguinetti M, Manicone PF, Rosa MA, Maccauro G.

Eur Rev Med Pharmacol Sci. 2019 Apr;23(2 Suppl):252-257. doi: 10.26355/eurrev_201904_17499.

18.

Diabetic foot infections: a comprehensive overview.

Pitocco D, Spanu T, Di Leo M, Vitiello R, Rizzi A, Tartaglione L, Fiori B, Caputo S, Tinelli G, Zaccardi F, Flex A, Galli M, Pontecorvi A, Sanguinetti M.

Eur Rev Med Pharmacol Sci. 2019 Apr;23(2 Suppl):26-37. doi: 10.26355/eurrev_201904_17471.

19.

Anti-tumor necrosis factor α therapy associates to type 17 helper T lymphocytes immunological shift and significant microbial changes in dextran sodium sulphate colitis.

Petito V, Graziani C, Lopetuso LR, Fossati M, Battaglia A, Arena V, Scannone D, Quaranta G, Quagliariello A, Del Chierico F, Putignani L, Masucci L, Sanguinetti M, Sgambato A, Gasbarrini A, Scaldaferri F.

World J Gastroenterol. 2019 Mar 28;25(12):1465-1477. doi: 10.3748/wjg.v25.i12.1465.

20.

ESICM/ESCMID task force on practical management of invasive candidiasis in critically ill patients.

Martin-Loeches I, Antonelli M, Cuenca-Estrella M, Dimopoulos G, Einav S, De Waele JJ, Garnacho-Montero J, Kanj SS, Machado FR, Montravers P, Sakr Y, Sanguinetti M, Timsit JF, Bassetti M.

Intensive Care Med. 2019 Jun;45(6):789-805. doi: 10.1007/s00134-019-05599-w. Epub 2019 Mar 25.

PMID:
30911804
21.

Comparable Serum and Plasma 1,3-β-d-Glucan Values Obtained Using the Wako β-Glucan Test in Patients with Probable or Proven Fungal Diseases.

De Carolis E, Marchionni F, Torelli R, Posteraro P, De Pascale G, Carelli S, Sanguinetti M, Posteraro B.

J Clin Microbiol. 2019 Apr 26;57(5). pii: e00149-19. doi: 10.1128/JCM.00149-19. Print 2019 May. No abstract available.

PMID:
30842228
22.

In vitro Evaluation of BACT/ALERT® VIRTUO®, BACT/ALERT 3D®, and BACTEC™ FX Automated Blood Culture Systems for Detection of Microbial Pathogens Using Simulated Human Blood Samples.

Menchinelli G, Liotti FM, Fiori B, De Angelis G, D'Inzeo T, Giordano L, Posteraro B, Sabatucci M, Sanguinetti M, Spanu T.

Front Microbiol. 2019 Feb 19;10:221. doi: 10.3389/fmicb.2019.00221. eCollection 2019.

23.

Educational interventions alone and combined with port protector reduce the rate of central venous catheter infection and colonization in respiratory semi-intensive care unit.

Inchingolo R, Pasciuto G, Magnini D, Cavalletti M, Scoppettuolo G, Montemurro G, Smargiassi A, Torelli R, Sanguinetti M, Spanu T, Corbo GM, Richeldi L.

BMC Infect Dis. 2019 Mar 4;19(1):215. doi: 10.1186/s12879-019-3848-z.

24.

Clostridium difficile: trend in an Italian Tertiary Care Hospital during fifteen years, 2002-2016.

Masucci L, Nicolotti N, Graffeo R, Tamburrano A, Archibusacci CM, Nagel D, Quaranta G, Eisendle K, Primus S, Romano L, Mazzella P, Posteraro B, Cammarota G, Sanguinetti M.

Minerva Med. 2019 Apr;110(2):168-171. doi: 10.23736/S0026-4806.18.05740-3. No abstract available.

PMID:
30821431
25.

Fish-derived antimicrobial peptides: Activity of a chionodracine mutant against bacterial models and human bacterial pathogens.

Buonocore F, Picchietti S, Porcelli F, Della Pelle G, Olivieri C, Poerio E, Bugli F, Menchinelli G, Sanguinetti M, Bresciani A, Gennari N, Taddei AR, Fausto AM, Scapigliati G.

Dev Comp Immunol. 2019 Jul;96:9-17. doi: 10.1016/j.dci.2019.02.012. Epub 2019 Feb 18.

PMID:
30790604
26.

Evaluation of Mass Spectrometry-Based Detection of Panfungal Serum Disaccharide for Diagnosis of Invasive Fungal Infections: Results from a Collaborative Study Involving Six European Clinical Centers.

Cornu M, Sendid B, Mery A, François N, Malgorzata M, Letscher-Bru V, De Carolis E, Damonti L, Titecat M, Bochud PY, Alanio A, Sanguinetti M, Viscoli C, Herbrecht R, Guerardel Y, Poulain D.

J Clin Microbiol. 2019 Apr 26;57(5). pii: e01867-18. doi: 10.1128/JCM.01867-18. Print 2019 May.

27.

Use of Aspergillus fumigatus real-time PCR in bronchoalveolar lavage samples (BAL) for diagnosis of invasive aspergillosis, including azole-resistant cases, in high risk haematology patients: the need for a combined use with galactomannan.

Mikulska M, Furfaro E, De Carolis E, Drago E, Pulzato I, Borghesi ML, Zappulo E, Raiola AM, Grazia CD, Del Bono V, Cittadini G, Angelucci E, Sanguinetti M, Viscoli C.

Med Mycol. 2019 Feb 7. doi: 10.1093/mmy/myz002. [Epub ahead of print]

PMID:
30753590
28.

ESCMID-EUCIC clinical guidelines on decolonization of multidrug-resistant Gram-negative bacteria carriers.

Tacconelli E, Mazzaferri F, de Smet AM, Bragantini D, Eggimann P, Huttner BD, Kuijper EJ, Lucet JC, Mutters NT, Sanguinetti M, Schwaber MJ, Souli M, Torre-Cisneros J, Price JR, Rodríguez-Baño J.

Clin Microbiol Infect. 2019 Jul;25(7):807-817. doi: 10.1016/j.cmi.2019.01.005. Epub 2019 Jan 29.

29.

Antimicrobial susceptibility testing of pathogens isolated from blood culture: a performance comparison of Accelerate Pheno™ and VITEK® 2 systems with the broth microdilution method.

De Angelis G, Posteraro B, Menchinelli G, Liotti FM, Spanu T, Sanguinetti M.

J Antimicrob Chemother. 2019 Jan 1;74(Supplement_1):i24-i31. doi: 10.1093/jac/dky532.

30.

Impact evaluation of a Critical Pathway for patients with Clostridium difficile infection: A pre-post analysis in a Third Level Referral Center.

de Belvis AG, Barbara A, Giubbini G, Traglia S, Angioletti C, Ianiro G, Masucci L, Sanguinetti M, Laurenti P, Cambieri A, Gasbarrini A, Ricciardi W, Cammarota G.

Int J Infect Dis. 2019 Mar;80:105-110. doi: 10.1016/j.ijid.2019.01.025. Epub 2019 Jan 22.

31.

Performance evaluation of the (1,3)-β-D-glucan detection assay in non-intensive care unit adult patients.

Murri R, Camici M, Posteraro B, Giovannenze F, Taccari F, Ventura G, Scoppettuolo G, Sanguinetti M, Cauda R, Fantoni M.

Infect Drug Resist. 2018 Dec 20;12:19-24. doi: 10.2147/IDR.S181489. eCollection 2019.

32.

A protein chimera self-assembling unit for drug delivery.

Amalfitano A, Martini C, Nocca G, Papi M, De Spirito M, Sanguinetti M, Vitali A, Bugli F, Arcovito A.

Biotechnol Prog. 2019 Mar;35(2):e2769. doi: 10.1002/btpr.2769. Epub 2018 Dec 27.

PMID:
30575331
33.

Rhodotorula infection in haematological patient: Risk factors and outcome.

Potenza L, Chitasombat MN, Klimko N, Bettelli F, Dragonetti G, Del Principe MI, Nucci M, Busca A, Fracchiolla N, Sciumè M, Spolzino A, Delia M, Mancini V, Nadali GP, Dargenio M, Shadrivova O, Bacchelli F, Aversa F, Sanguinetti M, Luppi M, Kontoyiannis DP, Pagano L.

Mycoses. 2019 Mar;62(3):223-229. doi: 10.1111/myc.12875. Epub 2018 Dec 28.

PMID:
30525252
34.

Desirability of outcome ranking (DOOR) for comparing diagnostic tools and early therapeutic choices in patients with suspected candidemia.

Giacobbe DR, Signori A, Tumbarello M, Ungaro R, Sarteschi G, Furfaro E, Mikulska M, Sanguinetti M, Posteraro B, Losito AR, De Pascale G, Del Bono V, Viscoli C.

Eur J Clin Microbiol Infect Dis. 2019 Feb;38(2):413-417. doi: 10.1007/s10096-018-3441-1. Epub 2018 Nov 30.

PMID:
30506332
35.

Graphene oxide coatings prevent Candida albicans biofilm formation with a controlled release of curcumin-loaded nanocomposites.

Palmieri V, Bugli F, Cacaci M, Perini G, Maio F, Delogu G, Torelli R, Conti C, Sanguinetti M, Spirito M, Zanoni R, Papi M.

Nanomedicine (Lond). 2018 Nov;13(22):2867-2879. doi: 10.2217/nnm-2018-0183. Epub 2018 Nov 15.

PMID:
30431405
36.

Developing definitions for invasive fungal diseases in critically ill adult patients in intensive care units. Protocol of the FUNgal infections Definitions in ICU patients (FUNDICU) project.

Bassetti M, Scudeller L, Giacobbe DR, Lamoth F, Righi E, Zuccaro V, Grecchi C, Rebuffi C, Akova M, Alastruey-Izquierdo A, Arikan-Akdagli S, Azoulay E, Blot SI, Cornely OA, Lass-Flörl C, Koehler P, Cuenca-Estrella M, de Lange DW, De Rosa FG, De Waele JJ, Dimopoulos G, Garnacho-Montero J, Hoenigl M, Kanj SS, Maertens J, Martin-Loeches I, Muñoz P, Kullberg BJ, Agvald-Ohman C, Poulakou G, Rello J, Sanguinetti M, Taccone FS, Timsit JF, Torres A, Vazquez JA, Calandra T; from the Study Group for Infections in Critically Ill Patients (ESGCIP) and the Fungal Infection Study Group (EFISG) of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID); European Society of Intensive Care Medicine (ESICM); European Confederation of Medical Mycology (ECMM); Mycoses Study Group Education and Research Consortium (MSGERC).

Mycoses. 2019 Apr;62(4):310-319. doi: 10.1111/myc.12869. Epub 2019 Jan 22.

PMID:
30426598
37.

Influence of hepatitis C virus eradication with direct-acting antivirals on the gut microbiota in patients with cirrhosis.

Ponziani FR, Putignani L, Paroni Sterbini F, Petito V, Picca A, Del Chierico F, Reddel S, Calvani R, Marzetti E, Sanguinetti M, Gasbarrini A, Pompili M.

Aliment Pharmacol Ther. 2018 Dec;48(11-12):1301-1311. doi: 10.1111/apt.15004. Epub 2018 Oct 22.

PMID:
30345704
38.

Method-Dependent Epidemiological Cutoff Values for Detection of Triazole Resistance in Candida and Aspergillus Species for the Sensititre YeastOne Colorimetric Broth and Etest Agar Diffusion Methods.

Espinel-Ingroff A, Turnidge J, Alastruey-Izquierdo A, Botterel F, Canton E, Castro C, Chen YC, Chen Y, Chryssanthou E, Dannaoui E, Garcia-Effron G, Gonzalez GM, Govender NP, Guinea J, Kidd S, Lackner M, Lass-Flörl C, Linares-Sicilia MJ, López-Soria L, Magobo R, Pelaez T, Quindós G, Rodriguez-Iglesia MA, Ruiz MA, Sánchez-Reus F, Sanguinetti M, Shields R, Szweda P, Tortorano A, Wengenack NL, Bramati S, Cavanna C, DeLuca C, Gelmi M, Grancini A, Lombardi G, Meletiadis J, Negri CE, Passera M, Peman J, Prigitano A, Sala E, Tejada M.

Antimicrob Agents Chemother. 2018 Dec 21;63(1). pii: e01651-18. doi: 10.1128/AAC.01651-18. Print 2019 Jan.

39.

Liver Injury, Endotoxemia, and Their Relationship to Intestinal Microbiota Composition in Alcohol-Preferring Rats.

Posteraro B, Paroni Sterbini F, Petito V, Rocca S, Cubeddu T, Graziani C, Arena V, Vassallo GA, Mosoni C, Lopetuso L, Lorrai I, Maccioni P, Masucci L, Martini C, Gasbarrini A, Sanguinetti M, Colombo G, Addolorato G.

Alcohol Clin Exp Res. 2018 Dec;42(12):2313-2325. doi: 10.1111/acer.13900. Epub 2018 Oct 29.

PMID:
30320890
40.

Combined use of Quantiferon and HBHA-based IGRA supports tuberculosis diagnosis and therapy management in children.

Sali M, Buonsenso D, D'Alfonso P, De Maio F, Ceccarelli M, Battah B, Palucci I, Chiacchio T, Goletti D, Sanguinetti M, Valentini P, Delogu G.

J Infect. 2018 Dec;77(6):526-533. doi: 10.1016/j.jinf.2018.09.011. Epub 2018 Sep 26.

PMID:
30267797
41.

How are trainees in clinical microbiology and infectious diseases supervised in Europe? An international cross-sectional questionnaire survey by the Trainee Association of ESCMID.

Palacios-Baena ZR, Zapf TC, Ong DSY, Maraolo AE, Rönnberg C, Çimen C, Pulcini C, Rodríguez-Baño J, Sanguinetti M; Trainee Association of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID).

Eur J Clin Microbiol Infect Dis. 2018 Dec;37(12):2381-2387. doi: 10.1007/s10096-018-3386-4. Epub 2018 Sep 25.

PMID:
30255431
42.

Susceptibility Testing of Fungi to Antifungal Drugs.

Sanguinetti M, Posteraro B.

J Fungi (Basel). 2018 Sep 15;4(3). pii: E110. doi: 10.3390/jof4030110. Review.

43.

PE_PGRS3 of Mycobacterium tuberculosis is specifically expressed at low phosphate concentration, and its arginine-rich C-terminal domain mediates adhesion and persistence in host tissues when expressed in Mycobacterium smegmatis.

De Maio F, Battah B, Palmieri V, Petrone L, Corrente F, Salustri A, Palucci I, Bellesi S, Papi M, Rubino S, Sali M, Goletti D, Sanguinetti M, Manganelli R, De Spirito M, Delogu G.

Cell Microbiol. 2018 Dec;20(12):e12952. doi: 10.1111/cmi.12952. Epub 2018 Sep 26.

PMID:
30192424
44.

Fatal fulminant cryptococcemia complicating sarcoidosis: Is it to be expected?

Posteraro P, Vacca K, Celi M, De Angelis G, Vella A, Sanguinetti M, Posteraro B.

Med Mycol Case Rep. 2018 Aug 16;22:42-44. doi: 10.1016/j.mmcr.2018.08.006. eCollection 2018 Dec.

45.

ESCMID white paper: a guide on ESCMID guidance documents.

Scudeller L, Rodríguez-Baño J, Zinkernagel A, Tacconelli E, Akova M, Friedrich AW, Sanguinetti M, Paul M, Poljak M.

Clin Microbiol Infect. 2019 Feb;25(2):155-162. doi: 10.1016/j.cmi.2018.08.005. Epub 2018 Aug 24.

PMID:
30145398
46.

Expression profiling in a mammalian host reveals the strong induction of genes encoding LysM domain-containing proteins in Enterococcus faecium.

Cacaci M, Giraud C, Leger L, Torelli R, Martini C, Posteraro B, Palmieri V, Sanguinetti M, Bugli F, Hartke A.

Sci Rep. 2018 Aug 17;8(1):12412. doi: 10.1038/s41598-018-30882-z.

47.

Methodologies for in vitro and in vivo evaluation of efficacy of antifungal and antibiofilm agents and surface coatings against fungal biofilms.

Van Dijck P, Sjollema J, Cammue BP, Lagrou K, Berman J, d'Enfert C, Andes DR, Arendrup MC, Brakhage AA, Calderone R, Cantón E, Coenye T, Cos P, Cowen LE, Edgerton M, Espinel-Ingroff A, Filler SG, Ghannoum M, Gow NAR, Haas H, Jabra-Rizk MA, Johnson EM, Lockhart SR, Lopez-Ribot JL, Maertens J, Munro CA, Nett JE, Nobile CJ, Pfaller MA, Ramage G, Sanglard D, Sanguinetti M, Spriet I, Verweij PE, Warris A, Wauters J, Yeaman MR, Zaat SAJ, Thevissen K.

Microb Cell. 2018 Jun 14;5(7):300-326. doi: 10.15698/mic2018.07.638. Review.

48.

Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes as Models for Cardiac Channelopathies: A Primer for Non-Electrophysiologists.

Garg P, Garg V, Shrestha R, Sanguinetti MC, Kamp TJ, Wu JC.

Circ Res. 2018 Jul 6;123(2):224-243. doi: 10.1161/CIRCRESAHA.118.311209.

49.

Risk factors for recurrence in patients with Clostridium difficile infection due to 027 and non-027 ribotypes.

Falcone M, Tiseo G, Iraci F, Raponi G, Goldoni P, Delle Rose D, Santino I, Carfagna P, Murri R, Fantoni M, Fontana C, Sanguinetti M, Farcomeni A, Antonelli G, Aceti A, Mastroianni C, Andreoni M, Cauda R, Petrosillo N, Venditti M.

Clin Microbiol Infect. 2019 Apr;25(4):474-480. doi: 10.1016/j.cmi.2018.06.020. Epub 2018 Jun 28.

PMID:
29964230
50.

Genome Editing of Induced Pluripotent Stem Cells to Decipher Cardiac Channelopathy Variant.

Garg P, Oikonomopoulos A, Chen H, Li Y, Lam CK, Sallam K, Perez M, Lux RL, Sanguinetti MC, Wu JC.

J Am Coll Cardiol. 2018 Jul 3;72(1):62-75. doi: 10.1016/j.jacc.2018.04.041.

Supplemental Content

Loading ...
Support Center